- Home
- FMY vs SRTS Comparison
FMY vs SRTS Comparison
Compare FMY & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMY | SRTS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 48.9M |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FMY | SRTS |
|---|---|---|
| Price | $11.55 | $2.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 2.6K | ★ 17.4K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 6.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.40 | $2.66 |
| 52 Week High | $12.39 | $5.49 |
Technical Indicators
Market Signals| Indicator | FMY | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 49.85 |
| Support Level | $11.43 | $2.87 |
| Resistance Level | $12.17 | $3.11 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 3.74 | 44.16 |
Price Performance
Historical ComparisonAbout FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.